VCEL Vericel Corporation

Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals, Dendreon, Genentech and Spectrum Pharmaceuticals Will Present at Informed Investors Biotech/Cancer Stocks Forum to be Webcast on Tuesday, December 16, 2003, 9 AM ET SAN FRANCISCO, Dec. 12 /PRNewswire/ -- Informed Investors will webcast the following presentations: What: Aastrom Biosciences, Inc. (NASDAQ:ASTM), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Dendreon Corp. (NASDAQ:DNDN), Genentech (NYSE:DNA), and Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) will give presentations at Informed Investors Biotech/Cancer Stocks Forum When: December 16, 2003 @ 9:00 AM Eastern Time Where: http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296 How: Live over the Internet -- Simply log on to the web at the address above. Contacts: Aastrom Biosciences -- Investor Relations, 734-930-5777, BioCryst Pharmaceuticals -- Michael A. Darwin, 205-444-4600, Dendreon -- Julie Rathbun, Investor Relations, (206) 829-1500 Genentech -- Diane Schrick, 650-225-1599, Spectrum Pharmaceuticals -- Anna Kazanchy, If you are unable to participate during the live webcast, the call will be available for replay at http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296. Aastrom Biosciences, Inc. is a late-stage development company focused on human cell-based therapies. BioCryst Pharmaceuticals, Inc. designs and develops novel drugs that block key enzymes essential to disease progression. Dendreon Corporation is a biotechnology company developing targeted therapies for cancer. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Spectrum Pharmaceuticals' primary focus is to develop in-licensed drugs for the treatment and supportive care of cancer patients. FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424, Corp.; Genentech; Spectrum Pharmaceuticals Inc. DATASOURCE: Aastrom Biosciences Inc.; BioCryst Pharmaceuticals, Inc.; Dendreon CONTACT: Aastrom Biosciences Investor Relations, +1-734-930-5777, ; Michael A. Darwin of BioCryst Pharmaceuticals, +1-205-444-4600, ; Julie Rathbun, Investor Relations, of Dendreon, +1-206-829-1500; Diane Schrick of Genentech, +1-650-225-1599, ; or Anna Kazanchy of Spectrum Pharmaceuticals, ; FORUM CONTACT: Janet Scharr of Informed Investors, +1-804-327-3424, Web site: http://www.informedinvestors.com/

Copyright